RD31 - Annual: Pharmacy Liaison Committee and Drug Utilization Review Board Report – FY2017 – December 15, 2017
Executive Summary: Annual report on the activities of the Pharmacy Liaison Committee and the prospective Drug Utilization Review (pro-DUR) Committee. |